Opioids, a class of drugs, are usually prescribed to treat pain. Use of prescribed opioid drug is safe for pain management. The drug class includes hydrocodone, morphine, heroin, oxycodone, fentanyl, codeine, and methadone. It is also used to treat diarrhea and as a cough suppressant. Opioids can be administered either through intravenous, liquids, pills, lozenges, or transdermal patches. Countries of North America and Europe are notorious for high levels of abuse of this drug. Opioids, such as hydrocodone, fentanyl, morphine, and codeine, have become a source of addiction in these regions due to easy availability of these drugs.
According to the World Drug Report, in 2014, around 17.4 million individuals across the world were affected by opioid drug abuse. However, regulatory agencies and global organizations, such as the World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), and Food and Drug Administration (FDA) are working towards limiting the abuse of opioids by creating awareness. For instance, in 2016, CDC limited the daily dose of opioids to 90 morphine milligram equivalent (MME).
Request For A Sample Of The Opioids agonist drugs Market Report: https://www.coherentmarketinsights.com/insight/request-sample/135
High prevalence of chronic pain across the globe is expected to augment the growth of the global opioids agonist drugs market over the forecast period. For instance, as reported by the American Academy of Pain Medicine, more than 1.8 billion individuals suffered from chronic pain in 2011. Moreover, according to the National Institutes of Health (NIH), one out of ten Americans suffer from chronic pain.
Furthermore, according to a study published in 2016 in the British Medical Journal, about one-third to half of the U.K. population suffer from chronic pain.
Factors such as high prevalence of chronic pain, diarrhea, and cough are expected to augment the growth of the global opioids agonist drugs market.
North America is expected to witness robust growth in the global opioids agonist drugs market due to the increasing demand or increasing sales of opioids. Meperidine, fentanyl, methadone, codeine, hydrocodone, and morphine are the most abused prescription opioids. Hydrocodone is the highly prescribed opioid in the U.S. Thus, countries of North America are notorious for high levels of abuse of this drug.
According to CDC’s 2015, people who are addicted to prescription opioid analgesics are 40 times more likely to be addicted to heroin. Moreover, in 2015, around 73% of all drug overdose deaths in the U.S. were due to opioids. The death incidence rose to nearly 33,000 in 2015 from 23,000 in 2012 in the U.S.
Request PDF Brochure with Latest Insights @
Drug abuse and increasing use of cannabis as a potential alternative for opioids is expected to hamper growth of the global opioids agonist drugs market.
By Product Type:
By Therapeutic Application:
- Pain Management
- Cough Treatment
- Diarrhea Treatment
Major players operating in the global opioids agonist drugs market are Endo Pharmaceuticals Inc., Egalet Corporation, Mallinckrodt Pharmaceuticals, Sanofi, Pfizer Inc., Actavis Plc., Janssen Pharmaceuticals, Inc., Boehringer Ingelheim, Purdue Pharma, and Sun Pharmaceutical Industries Ltd., among others.
Reasons to Buy this Opioids Agonist Drugs Market Report
➡ Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging Opioids Agonist Drugs market
➡Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging Opioids Agonist Drugs market
➡Leading company profiles reveal details of key Opioids Agonist Drugs market players emerging five operations and financial performance
➡Add weight to presentations and pitches by understanding the future growth prospects of the emerging Opioids Agonist Drugs market with five year historical forecasts
➡Compares data from North America, South America, Asia Pacific Europe and Middle East Africa, alongside individual chapters on each region .
Buy This Complete Business Report With Flat 30% Off @
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Opioids Agonist Drugs Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak: Opioids Agonist Drugs Industry Impact
Chapter 2 Global Opioids Agonist Drugs Competition by Types, Applications, and Top Regions and Countries
2.1 Global Opioids Agonist Drugs (Volume and Value) by Type
2.3 Global Opioids Agonist Drugs (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Opioids Agonist Drugs Sales, Consumption, Export, Import by Regions
Chapter 5 North America Opioids Agonist Drugs Market Analysis
Chapter 6 East Asia Opioids Agonist Drugs Market Analysis
Chapter 7 Europe Opioids Agonist Drugs Market Analysis
Chapter 8 South Asia Opioids Agonist Drugs Market Analysis
Chapter 9 Southeast Asia Opioids Agonist Drugs Market Analysis
Chapter 10 Middle East Opioids Agonist Drugs Market Analysis
Chapter 11 Africa Opioids Agonist Drugs Market Analysis
Chapter 12 Oceania Opioids Agonist Drugs Market Analysis
Chapter 13 South America Opioids Agonist Drugs Market Analysis
Chapter 14 Company Profiles and Key Figures in Opioids Agonist Drugs Business
Chapter 15 Global Opioids Agonist Drugs Market Forecast (2021-2028)
Chapter 16 Conclusions
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027